68
50
Growth Score
-12 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
362756
San Rocco Therapeutics is a development of treatments for life-threatening diseases with a special focus on rare diseases.
- Patrick Girondi: Founder, President, and CEO
- Chris Ballas: Chief Scientific AdvisorPast Role: Rocket Pharmaceuticals, Vice President of Manufacturing
About the Company
San Rocco Therapeutics offers development of treatments for life-threatening diseases with a special focus on rare diseases, commonly referred to as “orphan diseases.” SRT is developing its portfolio of pharmaceutical products to correct the erroneous gene expression associated with many of these diseases. SRT therapies are currently being
developed for hemoglobinopathies and selected cancers.
